877-272-6226
News and Stories About FDA
Lynparza Approved for Pancreatic Cancer Patients Identified by Testing
Dec 30, 2019
Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE
FDA Hosts Patient Advocacy Leaders
Oct 10, 2019
Patient advocacy leaders, including Pancreatic Cancer Action Network’s (PanCAN) chief medical officer Victoria Manax, MD, gave opening remarks at the […]
READ MORE
